SCA
IART icon

Secor Capital Advisors’s Integra LifeSciences IART Stock Holding History

Secor Capital Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-18,762
Closed -$790K – 517
2017
Q1 		$790K Buy
+18,762
New +$802K 0.09% 279

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Secor Capital Advisors's IART Position: Q2 2017 in Review

Secor Capital Advisors sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 18,762 shares — an estimated $790K sold.

Secor Capital Advisors first reported a position in IART in Q1 2017 and held it in 1 quarter. The position peaked at $790K in Q1 2017. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

  • Secor Capital Advisors reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 18,762 Integra LifeSciences shares in Q2 2017, an estimated $790K.
  • Secor Capital Advisors first reported a position in Integra LifeSciences in Q1 2017 and held it in 1 quarter.
  • Secor Capital Advisors's Integra LifeSciences position peaked at $790K in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.